Aandeel A950160 KOLON TISSUEGENE, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Kolon TissueGene, Inc.

Aandelen

A950160

KR8840120008

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Kolon TissueGene, Inc. announced that it has received $30.000024 million in funding
Kolon TissueGene, Inc. announced that it has received KRW 39.999032395 billion in funding from Kolon Corporation
Kolon TissueGene, Inc. announced that it expects to receive $30.000024 million in funding
Kolon TissueGene, Inc. announced that it expects to receive KRW 30 million in funding from Kolon Corporation
Kolon TissueGene, Inc. announced that it has received KRW 33 billion in funding from a group of investors
Kolon TissueGene, Inc. announced that it expects to receive KRW 33 billion in funding from a group of investors
Kolon TissueGene, Inc. announced that it has received $29.637774 million in funding from Kolon Corporation
Kolon TissueGene, Inc. announced that it expects to receive $38.79881 billion in funding from Kolon Corporation and another investor
Kolon TissueGene, Inc. Resumes TG-C Phase III Studies in the U.S
Kolon TissueGene, Inc. announced that it has received KRW 29.140887075 billion in funding from Kolon Corporation
Kolon TissueGene, Inc. to Expand Indications for TG-C
Kolon TissueGene, Inc. announced that it expects to receive KRW 29.140887075 billion in funding from Kolon Corporation
Kolon TissueGene, Inc. Announces Plans to Resume US Phase III Clinical Trial For TG-C
Kolon TissueGene, Inc.(KOSDAQ:A950160) dropped from S&P Global BMI Index
Kolon TissueGene, Inc. to Start US Phase III Clinical Trial for Invossa™
TissueGene, Inc. has Changed its Name to Kolon TissueGene, Inc
Kolon TissueGene, Inc.(KOSDAQ:A950160) added to S&P Global BMI Index
Kolon TissueGene, Inc. has completed an IPO in the amount of KRW 202.5 billion.
Kolon TissueGene, Inc. has filed an IPO.
TissueGen® Inc. Names Lisa A. Fortier to its Scientific Advisory Board
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers A950160
  4. Nieuws Kolon TissueGene, Inc.
  5. Andere talen